Skip to main content
. 2020 Sep 18;13(9):252. doi: 10.3390/ph13090252

Figure 1.

Figure 1

The chemical architecture of promising anticancer sulfonamides in clinical trials or currently in-use pharmacotherapeutics with inhibition activity on the tumor-associated human carbonic anhydrases (Cas).